Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03512197
Title A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

acute myeloid leukemia


Daunorubicin + Midostaurin

Cytarabine + Idarubicin + Midostaurin

Cytarabine + Idarubicin


Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Additional content available in CKB BOOST